|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 176.50 AUD | +0.55% |
|
+1.27% | +2.23% |
| 01-13 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 12-23 | Australian shares end holiday-shortened week lower on profit-taking | RE |
| Capitalization | 57.13B 49.07B 45.53B 42.54B 79.19B 5,191B 85.1B 526B 207B 2,472B 214B 210B 9,032B | P/E ratio 2026 * |
22.7x | P/E ratio 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise value | 65.89B 56.59B 52.51B 49.06B 91.33B 5,987B 98.14B 607B 239B 2,851B 247B 242B 10,417B | EV / Sales 2026 * |
4.12x | EV / Sales 2027 * | 3.89x |
| Free-Float |
99.9% | Yield 2026 * |
2.59% | Yield 2027 * | 2.81% |
Last Transcript: CSL Limited
| 1 day | +0.55% | ||
| 1 week | +1.27% | ||
| Current month | +2.23% | ||
| 1 month | +1.44% | ||
| 3 months | -19.22% | ||
| 6 months | -31.42% | ||
| Current year | +2.23% |
| 1 week | 172.1 |  | 176.93 |
| 1 month | 168.29 | | 178.87 |
| Current year | 168.29 | | 176.93 |
| 1 year | 168 | | 282.2 |
| 3 years | 168 | | 314.28 |
| 5 years | 168 | | 319.78 |
| 10 years | 91.62 | | 342.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul McKenzie
CEO | Chief Executive Officer | 60 | 2023-03-05 |
Ken Lim
DFI | Director of Finance/CFO | 52 | 2025-10-06 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 64 | 2020-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2018-10-16 | |
Marie McDonald
BRD | Director/Board Member | 70 | 2013-08-13 |
Megan Clark
BRD | Director/Board Member | 68 | 2016-02-15 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.16% | 2.91% | 26 M€ | |
| +6.67% | 2.49% | 8 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.55% | +1.27% | -35.83% | -39.73% | 56.54B | |
| -1.20% | -7.97% | +7.55% | +1.17% | 75.21B | |
| -0.92% | +94.70% | +94.70% | +94.70% | 61.16B | |
| -2.90% | +2.38% | +40.81% | +232.95% | 58.53B | |
| -2.46% | -12.37% | +16.98% | -42.00% | 24.12B | |
| +0.92% | -0.62% | +47.66% | +29.10% | 20.85B | |
| -4.64% | -4.58% | +174.88% | +100.82% | 19.91B | |
| +10.10% | +1.37% | +68.46% | +1,361.21% | 18.8B | |
| +6.28% | +21.95% | +22.81% | -78.77% | 16.34B | |
| 0.00% | -1.28% | +125.69% | +807.86% | 14.7B | |
| Average | +0.57% | +1.86% | +56.37% | +246.73% | 36.62B | |
| Weighted average by Cap. | -0.34% | +0.49% | +41.28% | +150.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.99B 13.74B 12.74B 11.91B 22.17B 1,453B 23.82B 147B 57.99B 692B 59.97B 58.74B 2,528B | 16.71B 14.35B 13.31B 12.44B 23.16B 1,518B 24.88B 154B 60.58B 723B 62.65B 61.36B 2,641B |
| Net income | 2.57B 2.21B 2.05B 1.92B 3.57B 234B 3.83B 23.69B 9.33B 111B 9.65B 9.45B 407B | 3.42B 2.94B 2.73B 2.55B 4.75B 311B 5.1B 31.52B 12.42B 148B 12.84B 12.57B 541B |
| Net Debt | 8.76B 7.52B 6.98B 6.52B 12.14B 796B 13.05B 80.65B 31.76B 379B 32.85B 32.17B 1,385B | 7.86B 6.75B 6.26B 5.85B 10.89B 714B 11.71B 72.35B 28.5B 340B 29.47B 28.86B 1,242B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-19 | 176.50 $ | +0.55% | 529,362 |
| 26-01-16 | 175.53 $ | +0.14% | 1,136,494 |
| 26-01-15 | 175.28 $ | +1.03% | 881,337 |
| 26-01-14 | 173.49 $ | +0.10% | 1,112,245 |
| 26-01-13 | 173.32 $ | -1.02% | 682,808 |
Delayed Quote Australian S.E., January 19, 2026 at 12:13 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CSL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition